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ABSTRACT
Acanthosis nigricans (AN), an entity recognized since the 19th century, is a dermatopathy associated with insulin-resistant 
conditions, endocrinopathies, drugs, chromosome abnormalities and neoplasia. The latter, also known as malignant AN, is 
mostly related to abdominal neoplasms. Malignant AN occurs frequently among elderly patients. In these cases, the onset 
is subtle, and spreading involves the flexural regions of the body, particularly the axillae, palms, soles, and mucosa. Gastric 
adenocarcinoma is the most frequent associated neoplasia, but many others have been reported. Renal cell carcinoma 
(RCC), although already reported, is rarely associated with malignant AN. The authors report the case of a woman who 
was being treated for depression but presented a long-standing and marked weight loss, followed by darkening of the 
neck and the axillary regions. Physical examination disclosed a tumoral mass in the left flank and symmetrical, pigmented, 
velvety, verrucous plaques on both axillae, which is classical for AN. The diagnostic work-up disclosed a huge renal mass, 
which was resected and further diagnosed as a RCC. The post-operative period was uneventful and the skin alteration 
was evanescent at the first follow-up consultation. The authors call attention to the association of AN with RCC. 
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CASE REPORT
A 67-year-old woman sought medical attention 
complaining of progressive weight loss and loss of 
appetite over the last 10 months, which was treated 
with antidepressants because of the suspicion of a 
mood disorder. In the meantime, she noticed darkening 
of the skin, but her mucosa, palms, and soles were 
spared. At the time she was hospitalized, she had lost 
21 kg and presenting daily fever (38°C) accompanied 
by rigor and marked weakness. She brought the 
results of a normal colonoscopy and an upper digestive 
endoscopy, which had recently been performed. 
The physical examination disclosed a pale and cachectic 
patient weighing 43 kg (BMI of 17) with normal 
hemodynamic and respiratory parameters. The skin 
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of the neck, axillary, and inframammary regions was 
darkened and thickened with a velvety appearance, 
which is consistent with the clinical diagnosis of 
acanthosis nigricans (AN) (Figure 1).
Peripheral lymphadenopathy was not found 
and physical examination of the lungs and heart 
was normal. However, although the abdomen was 
flat and flaccid, a hardened and painless mass was 
easily palpable in the left flank. The abdominal 
computed tomography confirmed the presence of 
a voluminous and heterogeneous mass, measuring 
13.4 × 8.6 × 7.3 cm, predominantly hypoattenuating 
and with heterogeneous contrast enhancement. 
It anteriorly displaced the renal hilum, which was 
apparently without invasion (Figure 2).
The laboratory work-up revealed microcytic 
hypochromic anemia, thrombocytosis, normal renal 
function, and moderate hyponatremia. The skin 
biopsy showed thickened epidermis by marked 
hyperkeratosis and papillomatosis. The papillomatosis 
resulted from finger-like projections of the dermal 
papillae to the surface, which was lined by thin 
epidermis. In between these projections, the 
epidermis was thicker than the epidermis overlying 
the papillae. There was no melanocytic proliferation or 
significant hyperpigmentation of the epidermal basal 
layer. The dermis had no significant inflammation. 
The pathological findings were consistent with AN 
(Figure 3).
The patient was submitted to a laparoscopic 
left total nephrectomy followed by tumor removal 
through a Pfannenstiel incision. The surgical specimen 
comprised an irregular-contour monoblock weighing 
597 g and measuring 14.5 × 13.0 × 8.3 cm, which, 
at the cut surface, showed a tumor mass occupying 
nearly 85% of the renal parenchyma, extending until 
the renal sinus but apparently sparing the vascular 
structures. The remaining renal tissue showed the 
corticomedullary limit, which was partially preserved 
in less than 10% of the kidney (Figure 4).
The microscopic examination showed that the 
morphology was consistent with renal clear-cell 
Figure 1. Physical examination showing darkening and thickening of the skin. Note the darkening skin in the neck 
and the velvety appearance in the infra axillary region.
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Figure 2. Axial computed tomography of the abdomen after intravenous contrast medium injection showing a 
large, heterogeneous and mixed attenuating mass anteriorly displacing the left kidney.
Figure 3. Photomicrography of the skin showing epidermal thickening due to “finger-like” papillomatosis and 
hyperkeratosis without melanocytic proliferation.
Figure 4. Gross findings of the formalin fixed surgical specimen. A and B – The huge extension of the tumor 
presenting the golden color in some areas due to the intracellular lipid accumulation.
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carcinoma (Figure 5), Fuhrman 4 nuclear grade with 
necrosis extending into nearly 40% of the neoplasia. 
The tumor was restricted to the kidney but invasion 
was present within the fat tissue of the renal sinus, as 
well as in the lymphatics and the venules within the 
tumor. The surgical margins were free of tumor.
The post-operative period was uneventful and the 
patient was discharged on the seventh post-operative 
day with skin bleaching (Figure 6). She was referred to 
an oncological center for follow-up.
DISCUSSION
Renal cell carcinoma (RCC) accounts for 3% of 
all solid organ neoplasia, occurring mostly between 
the ages of 60 years and 70 years with a slight 
predominance among males.1 Although the typical 
presentation of RCC is represented by flank pain, 
palpable mass, and hematuria, only up to 20% 
of cases will present this triad, and it is common 
to diagnose large tumors in its origin before any 
previous accompanying symptoms. However, with 
the widespread use of imaging techniques, incidental 
diagnoses are becoming increasingly frequent, reaching 
almost 70% of cases.2 Nevertheless, the diagnosis is 
also frequently made by the metastatic presentation 
instead of being done through the detection of 
the primary tumor.3 In this setting the diagnosis is 
suspected or is held by manifestations on various areas 
and systems of the human body: (i) the skin; (ii) the 
musculoskeletal system; (iii) the nervous system; (iv) the 
blood system; (v) the vascular system; (vi) the lungs and 
pleura; (vii) the heart; (viii) the endocrine system; and 
(ix) the gastrointestinal system.3-18
Dermatological manifestations of RCC, although 
seldom observed, may be represented by nodules: 
(i) metastasis (presented in 3–6% of the RCC) mostly 
Figure 5. Photomicrography of the tumor. A and B – nests and sheets of epithelial cells with clear cytoplasm and 
distinct cell membrane, interspersed by a rich network of thin-walled vascular tissue (H&E, 200X). C and D – Note 
areas of eosinophilic cytoplasm (often seen in high-grade neoplasm) and nuclei of pleomorphic size and shape with 
loose chromatin, and the presence of macronucleoli characterizing the Fuhrman 4 nuclear grading.
Autopsy and Case Reports 2016;6(1):33-40
Campos FPF, Narvaez MRA, Reis PVS, et al.
37
found in the scalp, the thorax, and the abdomen;1,19-22 
or (ii) leukocytoclastic vasculitis, with or without 
ulceration.23 Even rarer, the skin manifestations may 
also be represented by paraneoplastic syndromes, such 
as AN, palmar fibromatosis, erythrodermia, and bullous 
pemphigoid.24,25
Paraneoplastic syndrome refers to conditions, 
signs, and symptoms secondary to the presence 
of a malignancy,26 which, in the case of RCC, may 
be present in up to 40% of the cases, and are 
also represented by fever, cachexia, Stauffer’s 
syndrome, polycytemia, hypercalcemia, hypertension, 
gynecomastia, galactorrhoea, and others, which 
subside after the tumor removal, and may upsurge 
with tumor relapse or metastatic disease.
Our patient’s situation represents one of those 
cases of pauci symptomatic RCC (only weight loss); 
however, the misinterpretation (mood disorder) of the 
cause of weight loss was very regrettable. Our patient 
was being followed by a mental health service where 
the clinical hypothesis was far from the correct 
diagnosis, giving an opportunity for the large growth 
of the tumor. The darkening of the skin was probably 
also neglected what added to the marked weight loss 
should have raised the suspicion for malignancy.
It is suspected that AN was first diagnosed in 
1867 by Mitchel.27 However, it was only in 1890 that 
Pollitzer28 and Janvosky29 described the verrucous 
hyperpigmented dermatosis, which was named 
“acanthosis nigricans.” Since then, many descriptions 
proliferated in the literature associating AN with many 
clinical conditions mostly related to insulin-resistance 
entities30 such as: (i) obesity (up to 70% may present 
AN);31 (ii) type-2 diabetes; (iii) metabolic syndrome;32 and 
(iv) polycistic ovary syndrome,33 other endocrinopathies 
(acromegaly, Cushing syndrome, hypothyroidism), 
Down syndrome, drug use (e.g. nicotinic acid, fusidic 
acid, and hormones), and genetic syndromes.34 AN more 
often involves the neck, axilla, the region under the 
breast, the groin, and other skin folds. Less commonly, 
the back of the neck, face, periumbilical and anogenital 
areas, palms, soles, and mucosa can be involved. 
The lesions are often symmetrical and characterized 
by brownish, thickened, dry, and rough skin, with 
a velvet or leather appearance, sometimes showing 
verrucous or papillomatous excrescences. Patients 
with AN may complain that they have a kind of grime 
they cannot get rid of. Microscopically, the lesion is 
characterized by papillary hypertrophy (papillomatosis) 
and hyperkeratosis. Hyperpigmentation is due to 
hyperkeratosis rather than an increase in melanin 
pigment in the skin.
In 1893, Ferdinand-Jean Darier first described 
the association of AN with malignancy (two cases 
with the descriptive title of “Dystrophie papilaire 
et pigmentaire”,35 which, although clinically very 
similar, usually affects palms and soles, with rapid 
onset and spread, afflicting the elderly population.34,36 
Among all malignancies, gastric adenocarcinoma is 
particularly associated with up to 61% of all malignant 
AN, followed by neoplasia of the ovary, lungs, and 
breast. Much less frequent, esophageal, intestinal, 
biliary bladder, pancreas, prostate, bladder, and other 
urothelial carcinoma have been reported in association 
with AN.36 Searching the PubMed database (irrespective 
of the period), using the keywords “acanthosis 
nigricans” crossed with “clear cell carcinoma,” 
“urothelial carcinoma,” “kidney,” “renal carcinoma,” 
and “paraneoplastic,” we found 168 citations related 
to malignant AN—among them the association with 
renal malignancy are described as follows. In the Riegel 
and Jacobs series,36 which comprised 277 cases of 
malignant AN, only 1 case of renal malignancy was 
reported; Moscardi et al.37 reported a case of renal 
malignancy without histological identification; and 
Lee et al.38 reported a case of renal urothelial carcinoma 
and AN. Therefore, we conclude that this association is 
very rare or at least under-reported. The pathogenesis 
of malignant AN, although not entirely understood, 
involves the action of an excess of transforming 
growth factor-α acting on the epidermal growth factor 
receptor inducing hyperstimulation of keratinocytes, 
which subside or disappear after tumor removal.39 
Generally, in 61% of cases the skin involvement is 
concomitant with the neoplasia; however, in 18% of 
cases AN appears many years before the neoplasia.40
In our case, although delayed, AN was diagnosed 
concomitantly with the neoplasia since the skin 
alteration appeared when the patient had already 
started losing weight.
An evaluation of the patient during the early 
post-operative period (around the seventh day after 
surgery) showed a slight evanescence of the darkening 
color of the skin. On the second month after surgery, 
the AN was no longer detected on the neck, which 
showed its close association with the presence of the 
neoplasia (Figure 6).
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The aim of this report was not only to show the 
association of RCC with AN, but also to call attention 
to this diagnosis in the elderly, most often when 
accompanied by weight loss without any other clinical 
feature that could raise the surveillance for neoplasia.
REFERENCES
1. Smyth LG, Casey RG, Quinlan DM. Renal cell carcinoma 
presenting as an ominous matachronous scalp metastasis. 
Can Urol Assoc J. 2010;4(3):E64-6. PMid:23293689.
2. Sountoulides P, Metaxa L, Cindolo L. Atypical presentations 
and rare metastatic sites of renal cell carcinoma: a review 
of case reports. J Med Case Rep. 2011;5(1):429. http://
dx.doi.org/10.1186/1752-1947-5-429. PMid:21888643.
3. Gharabaghi MA. Clinical Spectrum of Patients with Renal 
Cell Carcinoma. In: Amato R, editor. Emerging research 
and treatments in renal cell carcinoma. Rijeka: InTech; 
2012 [cited 2016 Jan 5]. chap 10; p. 229-44. Available 
from: http://www.intechopen.com/books/emerging-
research-and-treatments-in-renal-cellcarcinoma/clinical-
spectrum-of-patients-with-renal-cell-carcinoma
4. Fottner A, Szalantzy M, Wirthmann L, et al. Bone 
metastases from renal cell carcinoma: patient survival 
after surgical treatment. BMC Musculoskelet Disord. 
2010;11(1):145-50. http://dx.doi.org/10.1186/1471-
2474-11-145. PMid:20598157.
5. Klausner AP, Ost MC, Waterhouse RL Jr, Savage SJ. 
Occult renal cell carcinoma in a patient with polymyositis. 
Urology. 2002;59(5):773-6. http://dx.doi.org/10.1016/
S0090-4295(02)01533-9. PMid:11992921.
6. Respicio G, Shwaiki W, Abeles MA. 58-year-old man 
with anti-Jo-1 syndrome and renal cell carcinoma: a case 
report and discussion. Conn Med. 2007;71(3):151-3. 
PMid:17405398.
7. Koukoulis A, Cimas I, Gómara S. Paraneoplastic 
opsoclonus associated with papillary renal cell carcinoma. 
J Neurol Neurosurg Psychiatry. 1998;64(1):137-8. http://
dx.doi.org/10.1136/jnnp.64.1.137. PMid:9436748.
8. Roy MJ,  May EF,  Jabbari  B.  L i fe-threatening 
polyneuropathy heralding renal cell carcinoma. Mil Med. 
2002;167(12):986-9. PMid:12502172.
9. Mohammed Ilyas MI, Turner GD, Cranston D. Human 
chorionic gonadotropin secreting clear cell renal cell 
carcinoma with paraneoplastic gynaecomastia. Scand 
Figure 6. Skin examination of the neck region 50 days after tumor removal. Note the almost complete disappearance 
of the acanthosis nigricans in this area.
Autopsy and Case Reports 2016;6(1):33-40
Campos FPF, Narvaez MRA, Reis PVS, et al.
39
J Urol Nephrol. 2008;42(6):555-7. http://dx.doi.
org/10.1080/00365590802468834. PMid:19031270.
10. Hameed A, Pahuja A, Thwaini A, Nambirajan T. 
Subclavian vein thrombosis: an unusual presentation of 
renal cell carcinoma. Can Urol Assoc J. 2011;5(2):E27-8. 
http://dx.doi.org/10.5489/cuaj.10061. PMid:21470547.
11. Wallach JB, McGarry T, Torres J. Lymphangitic metastasis 
of recurrent renal cell carcinoma to the contralateral lung 
causing lymphangitic carcinomatosis and respiratory 
symptoms. Curr Oncol. 2011;18(1):e35-7. http://dx.doi.
org/10.3747/co.v18i1.647. PMid:21331270.
12. Suyama H, Igishi T, Makino H, et al. Bronchial artery 
embolization before interventional bronchoscopy 
to avoid uncontrollable bleeding: a case report of 
endobronchial metastasis of renal cell carcinoma. Intern 
Med. 2011;50(2):135-9. http://dx.doi.org/10.2169/
internalmedicine.50.3818. PMid:21245638.
13. Teresa P, Grazia ZM, Doriana M, Irene P, Michele 
S. Malignant effusion of chromophobe renal-cell 
carcinoma: Cytological and immunohistochemical 
findings. Diagn Cytopathol. 2012;40(1):56-61. http://
dx.doi.org/10.1002/dc.21599. PMid:22180239.
14. Okubo Y, Yonese J, Kawakami S, et al. Obstinate 
cough as a sole presenting symptom of non-metastatic 
renal cell carcinoma. Int J Urol. 2007;14(9):854-5. 
http://dx.doi.org/10.1111/j.1442-2042.2007.01832.x. 
PMid:17760755.
15. Miyamoto MI, Picard MH. Left atrial mass caused 
by metastatic renal cell carcinoma: an unusual site 
of tumor involvement mimicking myxoma. J Am 
Soc Echocardiogr. 2002;15(8):847-8. http://dx.doi.
org/10.1067/mje.2002.120508. PMid:12174358.
16. Gopan T, Toms SA, Prayson RA, Suh JH, Hamrahian AH, 
Weil RJ. Symptomatic pituitary metastases from renal cell 
carcinoma. Pituitary. 2007;10(3):251-9. http://dx.doi.
org/10.1007/s11102-007-0047-5. PMid:17541748.
17. Cimino-Mathews A, Sharma R, Netto GJ. Diagnostic 
use of PAX8, CAIX, TTF-1, and TGB in metastatic 
renal cell carcinoma of the thyroid. Am J Surg Pathol. 
2011;35(5):757-61. http://dx.doi.org/10.1097/
PAS.0b013e3182147fa8. PMid:21451364.
18. Kranidiotis GP, Voidonikola PT, Dimopoulos MK, 
Anastasiou-Nana MI. Stauffer’s syndrome as a prominent 
manifestation of renal cancer: a case report. Cases J. 
2009;2(1):49-52. http://dx.doi.org/10.1186/1757-1626-
2-49. PMid:19144140.
19. Mueller TJ, Wu H, Greenberg RE, et al. Cutaneous 
metastases from genitourinary malignancies. Urology. 
2004;63(6):1021-6. http://dx.doi.org/10.1016/j.
urology.2004.01.014. PMid:15183939.
20. Srinivasan N, Pakala A, Al-Kali A, Rathi S, Ahmad W. 
Papillary renal cell carcinoma with cutaneous metastases. 
Am J Med Sci. 2010;339(5):458-61. http://dx.doi.
org/10.1097/MAJ.0b013e3181d5678d. PMid:20234300.
21. Arrabal-Polo MA, Arias-Santiago SA, Aneiros-Fernandez 
J, Burkhardt-Perez P, Arrabal-Martin M, Naranjo-Sintes 
R. Cutaneous metastases in renal cell carcinoma: a 
case report. Cases J. 2009;2(1):7948-51. http://dx.doi.
org/10.4076/1757-1626-2-7948. PMid:19918439.
22. Dorairajan LN, Hemal AK, Aron M, et al. Cutaneous 
metastases in renal cel l  carcinoma. Urol Int. 
1999;63(3):164-7. http://dx.doi.org/10.1159/000030440. 
PMid:10738187.
23. Maynard JW, Christopher-Stine L, Gelber AC. Testicular 
pain followed by microscopic hematuria, a renal mass, 
palpable purpura, polyarthritis, and hematochezia. 
J Clin Rheumatol. 2010;16(8):388-91. http://dx.doi.
org/10.1097/RHU.0b013e3181fe8bbe. PMid:21085014.
24. Klein T, Rotterdam S, Noldus J, Hinkel A. Bullous pemphigoid 
is a rara paraneoplastic syndrome in patients with renal 
cell carcinoma. Scand J Urol Nephrol. 2009;43(4):334-
6. http://dx.doi.org/10.1080/00365590902811545. 
PMid:19308806.
25. Tebbe B, Schlippert U, Garbe C, Orfanos CE. Erythroderma 
“en nappes claires” as a marker of metastatic kidney 
cancer. Lasting, successful treatment with rIFN-alpha-2a. 
Hautarzt. 1991;42(5):324-7. PMid:1831444.
26. Palapattu GS, Kristo B, Rajfer J. Paraneoplastic syndromes 
in urologic malignancy: the many faces of renal cell 
carcinoma. Rev Urol. 2002;4(4):163-70. PMid:16985675.
27. Mitchel SW. Extensive encephaloid cancer of the 
subserous tissues of the peritoneum and pleura: Intensely 
bronzed-cloured skin; supra-renal capsules healthy. Proc. 
Path. Soc. Philad. 1867;3:35.
28. Politzer S. Acanthosis nigricans. In: Unna PG, Morris M, 
Besnier E, Duhring LA, editors. International atlas of rare 
skin diseases. London: HK Lewis & Co. Ltda; 1890. Pt. 
IV, No. XI, p. 6.
29. Janvosky V. Acanthosis nigricans. In: Unna PG, Morris 
M, Besnier E, Duhring LA, editors. International atlas of 
rare skin diseases. London: HK Lewis & Co. Ltda; 1890. 
Pt. IV, No. XI, p. 1.
30. Rendon MI, Cruz PD Jr, Sontheimer RD, Berg-stresser 
PR. Acanthosis nigricans: a cutaneous marker of 
tissue resistance to insulin. J Am Acad Dermatol. 
1989;21(3 pt 1):461-9. http://dx.doi.org/10.1016/S0190-
9622(89)70208-5. PMid:2674210.
31. Hud JA Jr, Cohen JB, Wagner JM, Cruz PD Jr. Prevalence 
and significance of acanthosis nigricans in an adult obese 
population. Arch Dermatol. 1992;128(7):941-4. http://
dx.doi.org/10.1001/archderm.1992.01680170073009. 
PMid:1626961.
32. Kalus AA, Chien AJ, Olerud JE. Chapter 151: diabetes 
mellitus and other endocrine diseases. In: Goldsmith 
Autopsy and Case Reports 2016;6(1):33-40
Acanthosis Nigricans associated with clear-cell renal cell carcinoma
40
LA, Katz SI, Gilchrest BA, et al., editors. Fitzpatrick’s 
dermatology in general medicine. 8th ed. New York: 
McGraw-Hill; 2012.
33. Stulberg DL, Clark N, Tovey D. Common hyperpigmantation 
disorders in adults: part II. Melanoma, seborreic keratoses, 
acanthosis nigricans, melasma, diabetic dermopathy, tinea 
versicolor and post inflammatory hyperpigmentation. Am 
Fam Physician. 2003;68(10):1963-8. PMid:14655805.
34. Kubicka-Wołkowska J, Dębska-Szmich S, Lisik-Habib M, 
Noweta M, Potemski P. Malignant acanthosis nigricans 
associated with prostate cancer: a case report. BMC Urol. 
2014;14(1):88. http://dx.doi.org/10.1186/1471-2490-14-
88. PMid:25399333.
35. Pollitzer S. Acanthosis nigricans: a symptom of a 
disoreder of the abdominal sympathetic. JAMA. 
1909;LIII(17):1369-73. http://dx.doi.org/10.1001/
jama.1909.92550170001001g.
36. Rigel DS, Jacobs MI. Malignant acanthosis nigricans: 
a review. J Dermatol Surg Oncol. 1980;6(11):923-7. 
http://dx.doi.org/10.1111/j.1524-4725.1980.tb01003.x. 
PMid:6257767.
37. Moscardi JL, Macedo NA, Espasandin JA, Piñeyro MI. 
Malignant acanthosis nigricans associated with a renal 
tumor. Int J Dermatol. 1993;32(12):893-4. http://
dx.doi.org/10.1111/j.1365-4362.1993.tb01410.x. 
PMid:8125695.
38. Lee HC, Ker KJ, Chong WS. Oral malignant acanthosis 
nigricans and tripe palms associated with renal urothelial 
carcinoma. JAMA Dermatol. 2015;151(12):1381-3. 
http://dx.doi.org/10.1001/jamadermatol.2015.2139. 
PMid:26309230.
39. Koyama S, Ikeda K, Sato M, et al. Transforming 
growth factor alpha (TGF- alpha)–producing gastric 
carcinoma with acanthosis nigricans: an endocrine 
effect of TGF- alpha in the pathogenesis of cutaneous 
paraneoplastic syndrome and epithelial hyperplasia of 
the esophagus. J Gastroenterol. 1997;32(1):71-7. http://
dx.doi.org/10.1007/BF01213299. PMid:9058298.
40. Krawczyk M, Mykała-Cieśla J, Kołodziej-Jaskuła A. 
Acanthosis nigricans as a paraneoplastic syndrome. Case 
reports and review of literature. Pol Arch Med Wewn. 
2009;119(3):180-3. PMid:19514649.
Conflict of interest: None
Submitted on: January 5th, 2016 
Accepted on: January 31st, 2016
Correspondence 
Fernando Peixoto Ferraz de Campos 
Internal Medicine Division – Hospital Universitário – University of São Paulo (USP) 
Av. Prof Lineu Prestes, 2565 – São Paulo/SP – Brazil 
CEP: 05508-000 
Phone: +55 (11) 3091-9275 
E-mail: fpfcampos@gmail.com
